Prothena Corp Public (PRTA) Enterprise Value (2012 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Enterprise Value of -$329.5 million in Q1 2026, down 7.13% quarter-over-quarter from -$307.5 million in Q4 2025, and up 21.17% on a YoY basis from -$271.9 million in Q1 2025.
Prothena Corp Public (PRTA) Enterprise Value (2012 - 2026) Analysis & Trends
Prothena Corp Public's Enterprise Value history runs 15 years deep, the most recent figure standing at -$329.5 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 21.17% year-over-year to -$329.5 million; the TTM figure through Mar 2026 stood at -$329.5 million (up 21.17% YoY), while the FY2025 annual figure was -$307.5 million, up 34.76% from the prior year.
- Enterprise Value was -$329.5 million for Q1 2026 at Prothena Corp Public, down from -$307.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$307.5 million in Q4 2025 to a low of -$710.4 million in Q4 2022.
- Historically, Enterprise Value has averaged -$515.1 million across 5 years, with a median of -$519.3 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value sank 57.69% in 2022, then surged 36.29% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$710.4 million in 2022, then climbed by 12.7% to -$620.2 million in 2023, then gained by 23.99% to -$471.4 million in 2024, then soared by 34.76% to -$307.5 million in 2025, then retreated by 7.13% to -$329.5 million in 2026.
- The last three Enterprise Value figures came in at -$329.5 million (Q1 2026), -$307.5 million (Q4 2025), and -$330.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | -329.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -329.46 Mn |
| Dec 31, 2025 | -307.53 Mn |
| Sep 30, 2025 | -330.80 Mn |
| Jun 30, 2025 | -371.40 Mn |
| Mar 31, 2025 | -417.94 Mn |
| Dec 31, 2024 | -471.39 Mn |
| Sep 30, 2024 | -519.26 Mn |
| Jun 30, 2024 | -564.12 Mn |
| Mar 31, 2024 | -547.86 Mn |
| Dec 31, 2023 | -620.18 Mn |
| Sep 30, 2023 | -672.25 Mn |
| Jun 30, 2023 | -660.46 Mn |
| Mar 31, 2023 | -686.18 Mn |
| Dec 31, 2022 | -710.41 Mn |
| Sep 30, 2022 | -495.63 Mn |
| Jun 30, 2022 | -508.80 Mn |
| Mar 31, 2022 | -542.99 Mn |
| Dec 31, 2021 | -579.09 Mn |
| Sep 30, 2021 | -600.10 Mn |
| Jun 30, 2021 | -401.18 Mn |